Pulmonary vein imaging with unenhanced three-dimensional balanced steady-state free precession MR angiography: Initial clinical evaluation

Radiology

Volumn 250, Issue 3, 2009, Pages 932-939

  François, Christopher J ^a,c   Tuite, David ^a   Deshpande, Vibhas ^b   Jerecic, Renate ^b   Weale, Peter ^b   Carr, James C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; PULMONARY VEIN; QUALITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SEGMENTED STEADY STATE FREE PRECESSION; STEADY STATE; THREE DIMENSIONAL IMAGING; VEIN DIAMETER;

ALGORITHMS; FEASIBILITY STUDIES; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY VEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 62649111656     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2502072137     Document Type: Article

References (44)

1. Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105:1077-1081.
2. Ghaye B, Szapiro D, Dacher JN, et al. Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging. RadioGraphics 2003;23(Spec Issue):S19-S33.
3. Kim YH, Marom EM, Herndon JE 2nd, McAdams HP. Pulmonary vein diameter, cross-sectional area, and shape: CT analysis. Radiology 2005;235:43-49.
4. Lacomis JM, Wigginton W, Fuhrman C, Schwartzman D, Armfield DR, Pealer KM. Multi-detector row CT of the left atrium and pulmonary veins before radio-frequency catheter ablation for atrial fibrillation. Radio-Graphics 2003;23(Spec Issue):S35-S48.
5. Marom EM, Herndon JE, Kim YH, McAdams HP. Variations in pulmonary venous drainage to the left atrium: implications for radiofrequency ablation. Radiology 2004;230:824-829.
6. Scharf C, Sneider M, Case I, et al. Anatomy of the pulmonary veins in patients with atrial fibrillation and effects of segmental ostial ablation analyzed by computed tomography. J Cardiovasc Electrophysiol 2003;14:150-155.
7. Ahmed J, Sohal S, Malchano ZJ, Holmvang G, Ruskin JN, Reddy VY. Three-dimensional analysis of pulmonary venous ostial and an-tral anatomy: implications for balloon catheter-based pulmonary vein isolation. J Cardiovasc Electrophysiol 2006;17:251-255.
8. Mansour M, Holmvang G, Sosnovik D, et al. Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J Cardiovasc Electro-physiol 2004;15:387-393.
9. van der Voort PH, van den Bosch H, Post JC, Meijer A. Determination of the spatial orientation and shape of pulmonary vein ostia by contrast-enhanced magnetic resonance angiography. Europace 2006;8:1-6.
10. White CS, Baffa JM, Haney PJ, Campbell AB, NessAiver M. Anomalies of pulmonary veins: usefulness of spin-echo and gradient-echo MR images. AJR Am J Roentgenol 1998;170:1365-1368.
11. WittkampfFH, Vonken EJ, Derksen R, et al. Pulmonary vein ostium geometry: analysis by magnetic resonance angiography. Circulation 2003;107:21-23.
12. Greil GF, Powell AJ, Gildein HP, Geva T. Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies. J Am Coll Cardiol 2002;39:335-341.
13. Ergun I, Keven K, Uruc I, et al. The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 2006;21:697-700.
14. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-649.
15. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-157.
16. Thomsen HS, Morcos SK, Dawson P. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)? Clin Radiol 2006;61: 905-906.
17. U.S. Food and Drug Administration. Information for Healthcare Professionals: Gadolinium-based contrast agents for magnetic resonance imaging (marketed as Magnevist, MultiHance, Omniscan, OptiMARK, ProHance)-Department of Health and Human Services. http://www.fda.gov/cder/drug/InfoSheets/HCP/gcca- 200705.htm. Published May 23, 2007. Accessed August 8, 2007.
18. Bi X, Deshpande V, Carr J, Li D. Coronary artery magnetic resonance angiography (MRA): a comparison between the whole-heart and volume-targeted methods using a T2-prepared SSFP sequence. J Cardiovasc Magn Reson 2006;8:703-707.
19. Carr JC, Simonetti O, Bundy J, Li D, Pereles S, Finn JP. Cine MR angiography of the heart with segmented true fast imaging with steady-state precession. Radiology 2001;219:828-834.
20. Liu X, Zhao X, Huang J, et al. Comparison of 3D free-breathing coronary MR angiography and 64-MDCT angiography for detection of coronary stenosis in patients with high calcium scores. AJR Am J Roentgenol 2007;189:1326-1332.
21. Pereles FS, McCarthy RM, Baskaran V, et al. Thoracic aortic dissection and aneurysm: evaluation with nonenhanced true FISP MR angiography in less than 4 minutes. Radiology 2002;223:270-274.
22. Sorensen TS, Beerbaum P, Korperich H, Pedersen EM. Three-dimensional, isotropic MRI: a unified approach to quantification and visualization in congenital heart disease. Int J Cardiovasc Imaging 2005;21:283-292.
23. Sorensen TS, Korperich H, Greil GF, et al. Operator-independent isotropic three-dimensional magnetic resonance imaging for morphology in congenital heart disease: a validation study. Circulation 2004;110:163-169.
24. Maki JH, Wilson GJ, Eubank WB, Glickerman DJ, Millan JA, Hoogeveen RM. Navigator-gated MRangiographyoftherenalarteries: apotential screening tool for renal artery stenosis. AJR Am J Roentgenol 2007;188:W540-W546.
25. Wyttenbach R, Braghetti A, Wyss M, et al. Renal artery assessment with nonenhanced steady-state free precession versus contrast-enhanced MR angiography. Radiology 2007;245:186-195.
26. Fink C, Ley S, Kroeker R, Requardt M, Kauczor HU, Bock M. Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest: combination of parallel imaging with view sharing (TREAT). Invest Radiol 2005;40:40-48.
27. Deshpande V, Krishnam MS, Ruehm SG, Finn JP, Laub GA. Non-contrast MR angiog-raphy of the heart and great vessels using SSFP with non-selective excitation [abstr]. In: Proceedings ofthe Fourteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2006;1935.
28. Heverhagen JT. Noise measurement and estimation in MR imaging experiments. Radiology 2007;245:638-639.
29. Kellman P, McVeigh ER. Image reconstruction in SNR units: a general method for SNR measurement. Magn Reson Med 2005;54:1439 -1447.
30. Huda W, Vance A. Patient radiation doses from adult and pediatric CT. AJR Am J Roentgenol 2007;188:540-546.
31. Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 2006;12:210-215.
32. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003;76:513-518.
33. Finn JP, Baskaran V, Carr JC, et al. Thorax: low-dose contrast-enhanced three-dimensional MR angiography with subsecond temporal resolution-initial results. Radiology 2002;224:896-904.
34. Korosec FR, Frayne R, Grist TM, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996;36: 345-351.
35. Lemola K, Sneider M, Desjardins B, et al. Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation. Circulation 2004;110:3655-3660.
36. Tsao HM, Wu MH, Higa S, et al. Anatomic relationship of the esophagus and left atrium: implication for catheter ablation of atrial fibrillation. Chest 2005;128:2581-2587.
37. Gil BN, Ran K, Tamar G, Shmuell F, Eli A. Prevalence of significant noncardiac findings on coronary multidetector computed tomography angiography in asymptomatic patients. J Comput Assist Tomogr 2007;31:1-4.
38. Mueller J, Jeudy J, Poston R, White CS. Cardiac CT angiography after coronary bypass surgery: prevalence of incidental findings. AJR Am J Roentgenol 2007;189:414-419.
39. Kirsch J, Araoz PA, Steinberg FB, Fletcher JG, McCollough CH, Williamson EE. Prevalence and significance of incidental extracardiac findings at 64-multidetector coronary TA. J Thorac Imaging 2007;22:330-334.
40. Onuma Y, Tanabe K, Nakazawa G, et al. Noncardiac findings in cardiac imaging with multidetector computed tomography. J Am oll Cardiol 2006;48:402-406.
41. Cademartiri F, Malago R, Belgrano M, et al. Spectrum of collateral findings in multislice CT coronary angiography. Radiol Med (Torino) 007;112:937-948.
42. Haller S, Kaiser C, Buser P, Bongartz G, Bremerich J. Coronary artery imaging with contrast-enhanced MDCT: extracardiac findings. JRAmJRoentgenol2006; 187:105-110.
43. Webb JA, Thomsen HS, Morcos SK. The use f iodinated and adolinium contrast media during pregnancy and lactation. Eur Radiol 005;15:1234-1240.
44. Peters DC, Wylie JV, Hauser TH, et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology 007;243:690-695.